In May, I wrote about some interesting rulings from the Middle District of Tennessee related to the “good cause” standard in False Claims Act (FCA) cases. Under 31 U.S.C. § 3730(c)(3), If the [...]

The False Claims Act (FCA) is often thought of as a healthcare fraud enforcement statute. This is not surprising, as over 80 percent of FCA settlements involve the healthcare industry, which [...]

Earlier this month, the U.S. Attorney’s Office for the Middle District of Tennessee (USAO) announced that it had charged Fadel Alshalabi, the owner and Chief Executive Officer of Spring Hill, [...]

It is not surprising that False Claim Act (FCA) and white-collar fraud headlines continue to be dominated by healthcare and COVID-19 relief fraud allegations. These undoubtedly remain areas of [...]

As I’ve noted before, healthcare is by far the industry most targeted by the Department of Justice (DOJ) and whistleblower lawyers. But this does not mean that other industries are safe; any [...]

Ladies and gentlemen, boys and girls, come gather around ye olde water cooler (virtually, you know, because COVID), it’s that time of year. It is time for the Department of Justice’s (DOJ) annual [...]

Under the False Claims Act (FCA), the United States gets an initial 60-day period to determine whether to intervene in a whistleblower’s qui tam action, during which time the complaint remains [...]

Two weeks ago, I posted a blog about a recent False Claims Act (FCA) settlement at the intersection of healthcare and procurement fraud. In early March, I wrote about FCA and compliance issues [...]